• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

埃及血吸虫的获得性免疫与流行病学

Acquired immunity and epidemiology of Schistosoma haematobium.

作者信息

Woolhouse M E, Taylor P, Matanhire D, Chandiwana S K

机构信息

Department of Zoology, University of Oxford, UK.

出版信息

Nature. 1991 Jun 27;351(6329):757-9. doi: 10.1038/351757a0.

DOI:10.1038/351757a0
PMID:1905786
Abstract

Human immune responses to schistosome infection have been characterized in detail. But there has been controversy over the relative importance of ecological factors (variation in exposure to infection) and immunological factors (acquired immunity) in determining the relationships between levels of infection and age typically found in areas where infection is endemic. Independent effects of exposure and age on the rates of reinfection with Schistosoma haematobium after chemotherapy have been demonstrated in the Gambia and Zimbabwe. This age effect could be the result of acquired immunity to infection. Indeed, allowing for variation in exposure and age, low rates of reinfection in the Gambia are correlated with high amounts of specific IgE antibodies--human IgE can kill S. mansoni schistosomulae in vitro. Further, animals can acquire immunologically mediated resistance to S. mansoni infection, although nonimmunological factors could also be involved. Acquisition of this immunity seems to be related to the cumulative effects of repeated infection and provides only partial protection. These characteristics are consistent with immuno-epidemiological data for both S. mansoni and S. haematobium infections of humans. We have now analysed age-prevalence data for human infection with S. haematobium, and find patterns of variation that are indeed consistent with the epidemiological effects of acquired immunity predicted by mathematical models.

摘要

人类对血吸虫感染的免疫反应已得到详细描述。但在感染流行地区,生态因素(感染暴露的差异)和免疫因素(获得性免疫)在决定感染水平与年龄之间典型关系时的相对重要性一直存在争议。在冈比亚和津巴布韦,已证实暴露和年龄对化疗后埃及血吸虫再感染率有独立影响。这种年龄效应可能是对感染获得性免疫的结果。的确,考虑到暴露和年龄的差异,冈比亚再感染率低与大量特异性IgE抗体相关——人IgE可在体外杀死曼氏血吸虫童虫。此外,动物可获得对曼氏血吸虫感染的免疫介导抗性,尽管也可能涉及非免疫因素。这种免疫力的获得似乎与反复感染的累积效应有关,且仅提供部分保护。这些特征与人类曼氏血吸虫和埃及血吸虫感染的免疫流行病学数据一致。我们现在分析了人类埃及血吸虫感染的年龄流行率数据,发现变异模式确实与数学模型预测的获得性免疫的流行病学效应一致。

相似文献

1
Acquired immunity and epidemiology of Schistosoma haematobium.埃及血吸虫的获得性免疫与流行病学
Nature. 1991 Jun 27;351(6329):757-9. doi: 10.1038/351757a0.
2
Cluster analysis of schistosome-specific antibody responses partitions the population into distinct epidemiological groups.血吸虫特异性抗体反应的聚类分析将人群分为不同的流行病学组。
Immunol Lett. 2005 Jan 31;96(2):231-40. doi: 10.1016/j.imlet.2004.08.017.
3
The epidemiology, immunology and morbidity of Schistosoma haematobium infections in diverse communities in Zimbabwe. I. The study design.
Trop Geogr Med. 1994;46(4 Spec No):227-32.
4
Epidemiology of mixed Schistosoma mansoni and Schistosoma haematobium infections in northern Senegal.塞内加尔北部曼氏血吸虫和埃及血吸虫混合感染的流行病学。
Int J Parasitol. 2012;42(3):305-11. doi: 10.1016/j.ijpara.2012.02.002. Epub 2012 Feb 16.
5
Human IgE, IgG4 and resistance to reinfection with Schistosoma haematobium.
Nature. 1991 Jan 17;349(6306):243-5. doi: 10.1038/349243a0.
6
Helminth- and Bacillus Calmette-Guérin-induced immunity in children sensitized in utero to filariasis and schistosomiasis.在子宫内对丝虫病和血吸虫病致敏的儿童中,蠕虫和卡介苗诱导的免疫。
J Immunol. 1999 Jun 1;162(11):6843-8.
7
Immuno-epidemiology of human Schistosoma haematobium infection: preferential IgG3 antibody responsiveness to a recombinant antigen dependent on age and parasite burden.埃及血吸虫感染的免疫流行病学:对重组抗原的IgG3抗体优先反应性取决于年龄和寄生虫负荷
BMC Infect Dis. 2006 Jun 9;6:96. doi: 10.1186/1471-2334-6-96.
8
A recombinant protein from Schistosoma mansoni useful for the detection of S. mansoni and Schistosoma haematobium antibodies.一种来自曼氏血吸虫的重组蛋白,可用于检测曼氏血吸虫和埃及血吸虫抗体。
J Parasitol. 1997 Aug;83(4):612-8.
9
Associations between specific antibody responses and resistance to reinfection in a Senegalese population recently exposed to Schistosoma mansoni.近期接触曼氏血吸虫的塞内加尔人群中特定抗体反应与再感染抵抗力之间的关联。
Trop Med Int Health. 2007 Mar;12(3):431-44. doi: 10.1111/j.1365-3156.2006.01805.x.
10
Biological and morphological changes in worms in mixed infection of Schistosoma mansoni and S. haematobium in hamsters.仓鼠感染曼氏血吸虫和埃及血吸虫混合感染时蠕虫的生物学和形态学变化。
J Egypt Soc Parasitol. 2002 Apr;32(1):59-68.

引用本文的文献

1
Associations of water contact frequency, duration, and activities with schistosome infection risk: A systematic review and meta-analysis.与水接触频率、时长和活动与血吸虫感染风险的关联:系统评价和荟萃分析。
PLoS Negl Trop Dis. 2023 Jun 14;17(6):e0011377. doi: 10.1371/journal.pntd.0011377. eCollection 2023 Jun.
2
Determining the optimal strategies to achieve elimination of transmission for Schistosoma mansoni.确定实现曼氏血吸虫传播消除的最佳策略。
Parasit Vectors. 2022 Feb 14;15(1):55. doi: 10.1186/s13071-022-05178-x.
3
What is the impact of acquired immunity on the transmission of schistosomiasis and the efficacy of current and planned mass drug administration programmes?
获得性免疫对血吸虫病传播和当前及计划中的大规模药物治疗方案效果的影响是什么?
PLoS Negl Trop Dis. 2021 Dec 1;15(12):e0009946. doi: 10.1371/journal.pntd.0009946. eCollection 2021 Dec.
4
Gender-related differences in prevalence, intensity and associated risk factors of Schistosoma infections in Africa: A systematic review and meta-analysis.非洲血吸虫感染的流行率、强度及相关危险因素的性别差异:系统评价和荟萃分析。
PLoS Negl Trop Dis. 2021 Nov 17;15(11):e0009083. doi: 10.1371/journal.pntd.0009083. eCollection 2021 Nov.
5
Whole-Proteome Differential Screening Identifies Novel Vaccine Candidates for Schistosomiasis japonica.全蛋白质差异筛选鉴定日本血吸虫病新型疫苗候选物。
J Infect Dis. 2021 Apr 8;223(7):1265-1274. doi: 10.1093/infdis/jiab085.
6
Assessing expanded community wide treatment for schistosomiasis: Baseline infection status and self-reported risk factors in three communities from the Greater Accra region, Ghana.评估扩大社区范围内血吸虫病治疗范围:加纳大阿克拉地区三个社区的基线感染状况和自我报告的风险因素。
PLoS Negl Trop Dis. 2020 Apr 27;14(4):e0007973. doi: 10.1371/journal.pntd.0007973. eCollection 2020 Apr.
7
Concomitant Immunity and Worm Senescence May Drive Schistosomiasis Epidemiological Patterns: An Eco-Evolutionary Perspective.伴随免疫和蠕虫衰老可能驱动血吸虫病流行病学模式:生态进化观点。
Front Immunol. 2020 Feb 25;11:160. doi: 10.3389/fimmu.2020.00160. eCollection 2020.
8
Comparison of School-Based and Community-Wide Mass Drug Administration for Schistosomiasis Control in an Area of Western Kenya with High Initial Infection Prevalence: A Cluster Randomized Trial.在肯尼亚西部一个初始感染率较高的地区,比较以学校为基础和以社区为基础的大规模药物治疗在控制血吸虫病方面的效果:一项集群随机试验。
Am J Trop Med Hyg. 2020 Feb;102(2):318-327. doi: 10.4269/ajtmh.19-0626.
9
Insufficiency of annual praziquantel treatment to control Schistosoma mansoni infections in adult women: A longitudinal cohort study in rural Tanzania.年度吡喹酮治疗不足以控制成年女性曼氏血吸虫感染:坦桑尼亚农村的一项纵向队列研究。
PLoS Negl Trop Dis. 2019 Nov 21;13(11):e0007844. doi: 10.1371/journal.pntd.0007844. eCollection 2019 Nov.
10
Vaccination or mass drug administration against schistosomiasis: a hypothetical cost-effectiveness modelling comparison.血吸虫病的疫苗接种或大规模药物治疗:一种假设的成本效益建模比较。
Parasit Vectors. 2019 Oct 23;12(1):499. doi: 10.1186/s13071-019-3749-4.